Cargando…
CHARACTERIZATION OF THE FIRST 391 REPORTS OF MYOCARDITIS AFTER MRNA COVID-19 VACCINES SUBMITTED TO THE VACCINE ADVERSE EVENT REPORTING SYSTEM - UNITED STATES
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American College of Cardiology Foundation. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972569/ http://dx.doi.org/10.1016/S0735-1097(22)02830-3 |
| _version_ | 1784679870662443008 |
|---|---|
| author | Rodriguez-Nava, Guillermo Egoryan, Goar Prasai, Paritosh Yanez-Bello, Maria Adriana Trelles-Garcia, Daniela Patricia |
| author_facet | Rodriguez-Nava, Guillermo Egoryan, Goar Prasai, Paritosh Yanez-Bello, Maria Adriana Trelles-Garcia, Daniela Patricia |
| author_sort | Rodriguez-Nava, Guillermo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8972569 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American College of Cardiology Foundation. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89725692022-04-01 CHARACTERIZATION OF THE FIRST 391 REPORTS OF MYOCARDITIS AFTER MRNA COVID-19 VACCINES SUBMITTED TO THE VACCINE ADVERSE EVENT REPORTING SYSTEM - UNITED STATES Rodriguez-Nava, Guillermo Egoryan, Goar Prasai, Paritosh Yanez-Bello, Maria Adriana Trelles-Garcia, Daniela Patricia J Am Coll Cardiol Spotlight on Special Topics American College of Cardiology Foundation. Published by Elsevier Inc. 2022-03-08 2022-04-01 /pmc/articles/PMC8972569/ http://dx.doi.org/10.1016/S0735-1097(22)02830-3 Text en © 2022 American College of Cardiology Foundation Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Spotlight on Special Topics Rodriguez-Nava, Guillermo Egoryan, Goar Prasai, Paritosh Yanez-Bello, Maria Adriana Trelles-Garcia, Daniela Patricia CHARACTERIZATION OF THE FIRST 391 REPORTS OF MYOCARDITIS AFTER MRNA COVID-19 VACCINES SUBMITTED TO THE VACCINE ADVERSE EVENT REPORTING SYSTEM - UNITED STATES |
| title | CHARACTERIZATION OF THE FIRST 391 REPORTS OF MYOCARDITIS AFTER MRNA COVID-19 VACCINES SUBMITTED TO THE VACCINE ADVERSE EVENT REPORTING SYSTEM - UNITED STATES |
| title_full | CHARACTERIZATION OF THE FIRST 391 REPORTS OF MYOCARDITIS AFTER MRNA COVID-19 VACCINES SUBMITTED TO THE VACCINE ADVERSE EVENT REPORTING SYSTEM - UNITED STATES |
| title_fullStr | CHARACTERIZATION OF THE FIRST 391 REPORTS OF MYOCARDITIS AFTER MRNA COVID-19 VACCINES SUBMITTED TO THE VACCINE ADVERSE EVENT REPORTING SYSTEM - UNITED STATES |
| title_full_unstemmed | CHARACTERIZATION OF THE FIRST 391 REPORTS OF MYOCARDITIS AFTER MRNA COVID-19 VACCINES SUBMITTED TO THE VACCINE ADVERSE EVENT REPORTING SYSTEM - UNITED STATES |
| title_short | CHARACTERIZATION OF THE FIRST 391 REPORTS OF MYOCARDITIS AFTER MRNA COVID-19 VACCINES SUBMITTED TO THE VACCINE ADVERSE EVENT REPORTING SYSTEM - UNITED STATES |
| title_sort | characterization of the first 391 reports of myocarditis after mrna covid-19 vaccines submitted to the vaccine adverse event reporting system - united states |
| topic | Spotlight on Special Topics |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972569/ http://dx.doi.org/10.1016/S0735-1097(22)02830-3 |
| work_keys_str_mv | AT rodrigueznavaguillermo characterizationofthefirst391reportsofmyocarditisaftermrnacovid19vaccinessubmittedtothevaccineadverseeventreportingsystemunitedstates AT egoryangoar characterizationofthefirst391reportsofmyocarditisaftermrnacovid19vaccinessubmittedtothevaccineadverseeventreportingsystemunitedstates AT prasaiparitosh characterizationofthefirst391reportsofmyocarditisaftermrnacovid19vaccinessubmittedtothevaccineadverseeventreportingsystemunitedstates AT yanezbellomariaadriana characterizationofthefirst391reportsofmyocarditisaftermrnacovid19vaccinessubmittedtothevaccineadverseeventreportingsystemunitedstates AT trellesgarciadanielapatricia characterizationofthefirst391reportsofmyocarditisaftermrnacovid19vaccinessubmittedtothevaccineadverseeventreportingsystemunitedstates |